Namita Thapar Shares Message, on Emcure Pharmaceuticals Listing
Namita Thapar, the executive director of Emcure Pharmaceuticals Ltd, sent an emotional statement praising the company.
Emcure Pharmaceuticals Ltd’s executive director, Namita Thapar, shared an emotional message on social media platform X (formerly Twitter) congratulating the company after it was listed at a 31 percent price premium.
In the post, she said, “Emotional morning today… we got listed at NSE 🙂 68 times oversubscribed, listed at 31% price premium, but my Mirza Ghalib Shayari sums up my feelings… congratulations, Team Emcure!”
In the video, she recited Mirza Ghalib’s shayari: “Hazaaron khwahishen aisi ke har khwahish pe dam nikle, bohat niklay mere armaan, lekin phir bhi kam nikle.”
Listing Details and Market Performance:
Emcure Pharmaceuticals listed at ₹1,325.05, up 31.45 percent on both the BSE and the NSE on July 10. The stock closed at a premium of over 35 percent against the issue price of ₹1,008 in the trading session.
In volume terms, 12.62 lakh shares of Emcure Pharmaceuticals were traded on the BSE, and 140.08 lakh shares on the NSE. With this, the company’s market valuation stood at ₹25,695.63 crore on Wednesday.
Namita Thapar talks about IPO Details and Usage of Funds:
The ₹1,952 crore initial public offering (IPO) received 67.87 times subscription on the final day of the offer. The Bain Capital-backed IPO had a price band of ₹960-1,008 per share and included a fresh issuance of equity shares worth ₹800 crore and an offer of sale (OFS) of 1.14 crore shares worth ₹1,152 crore.
The company will use the net proceeds from the IPO to pay debt and for general corporate purposes. The company develops, manufactures, and markets a broad range of pharmaceutical by-products globally.
